Jesper B Andersen, PhD - University of Copenhagen - Associate Professor

Jesper B Andersen

PhD

University of Copenhagen

Associate Professor

Copenhagen | Denmark

Main Specialties: Biology, Biotechnology, Gastroenterology, Hepatology

ORCID logohttps://orcid.org/0000-0003-1760-5244

Jesper B Andersen, PhD - University of Copenhagen - Associate Professor

Jesper B Andersen

PhD

Introduction

Primary Affiliation: University of Copenhagen - Copenhagen , Denmark

Specialties:

Education

Jun 2003 - Dec 2006
Aarhus Universitet
PhD
Molecular and Structural Biology
Aug 1996 - Jan 2003
Aarhus Universitet
MSc
Molecular and Structural Biology

Experience

Feb 2007 - Sep 2014
National Cancer Institute
Postdoc research fellow
CCR
Jun 2003 - Feb 2007
University of Maryland Baltimore
Research Fellow
Microbiology and Immunology, Greenebaum Cancer center
Jan 2003 - Jun 2003
Aarhus Universitet
Reearch Assistent
Molecular and Structural Biology
Jan 2014
Københavns Universitet
Associate Professor and Group leader
Health and Medical Sciences, Biotech Research and Innovation Centre (BRIC)

Publications

55Publications

2162Reads

-Profile Views

1074PubMed Central Citations

Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.

Hepatology 2018 09 12;68(3):949-963. Epub 2018 Jun 12.

Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hep.29764
Publisher Site
http://dx.doi.org/10.1002/hep.29764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599967PMC
September 2018
11 Reads
11.055 Impact Factor

Epigenome dysregulation in cholangiocarcinoma.

Biochim Biophys Acta Mol Basis Dis 2018 04 20;1864(4 Pt B):1423-1434. Epub 2017 Jun 20.

Biotech Research & Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen N, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2017.06.014DOI Listing
April 2018
8 Reads
1 Citation
4.882 Impact Factor

Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.

Trends Cancer 2018 03 21;4(3):239-255. Epub 2018 Feb 21.

Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen N, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2018.01.007DOI Listing
March 2018
3 Reads
1 Citation

Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.

Expert Rev Gastroenterol Hepatol 2017 Apr 13;11(4):349-356. Epub 2017 Feb 13.

a Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences , University of Copenhagen , Copenhagen N , Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474124.2017.1292127DOI Listing
April 2017
27 Reads
2.546 Impact Factor

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.

J Hepatol 2017 01 1;66(1):102-115. Epub 2016 Sep 1.

Center for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy; Program for Autoimmune Liver Diseases, International Center for Digestive Health, Department of Medicine and Surgery, University of Milan-Bicocca, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.08.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522599PMC
January 2017
63 Reads
16 Citations
11.340 Impact Factor

Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma.

Dig Dis 2016;34(4):440-51. Epub 2016 May 11.

Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000444562DOI Listing
January 2017
8 Reads
4 Citations
1.832 Impact Factor

Genetic Optimization of Liver Cancer Therapy: A Patient-Derived Primary Cancer Cell-Based Model.

Gastroenterology 2017 01 23;152(1):19-21. Epub 2016 Nov 23.

Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.11.030DOI Listing
January 2017
11 Reads
16.720 Impact Factor

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration.

Hepatology 2016 08 28;64(2):582-98. Epub 2016 Apr 28.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841553PMC
August 2016
65 Reads
4 Citations
11.055 Impact Factor

Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype.

Hepatology 2016 06 15;63(6):1888-99. Epub 2016 Mar 15.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874846PMC
June 2016
60 Reads
5 Citations
11.055 Impact Factor

Transcriptional, post-transcriptional and chromatin-associated regulation of pri-miRNAs, pre-miRNAs and moRNAs.

Nucleic Acids Res 2016 Apr 15;44(7):3070-81. Epub 2015 Dec 15.

Institute of Clinical Sciences MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK Department of Informatics, University of Bergen, Thormøhlensgate 55, N-5008 Bergen, Norway

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkv1354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838339PMC
April 2016
21 Reads
7 Citations
9.112 Impact Factor

Heterogeneity Among Liver Cancer--A Hurdle to Optimizing Therapy.

Gastroenterology 2016 Apr 26;150(4):818-21. Epub 2016 Feb 26.

Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2016.02.063DOI Listing
April 2016
12 Reads
2 Citations
16.720 Impact Factor

A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.

Mol Pharmacol 2016 Feb 14;89(2):263-72. Epub 2015 Dec 14.

Laboratory of Cell Biology (J-P.G., J.P.M., C-P.W., A.M.C., S.V.A., M.M.G.) and Laboratory of Experimental Carcinogenesis (J.B.A., S.S.T.), Center for Cancer Research, National Cancer Institute, and Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, Office of Science Management and Operations, National Institute of Allergy and Infectious Diseases (S.V.), National Institutes of Health, Bethesda, Maryland; and the Viral Technologies Group and Molecular Detection Group, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, Marylanld (R.K.B., K.P., W.E.B.)

View Article

Download full-text PDF

Source
http://molpharm.aspetjournals.org/content/early/2015/12/14/m
Web Search
http://molpharm.aspetjournals.org/content/89/2/263.full.pdf
Web Search
http://molpharm.aspetjournals.org/cgi/doi/10.1124/mol.115.10
Publisher Site
http://dx.doi.org/10.1124/mol.115.101360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727122PMC
February 2016
78 Reads
5 Citations
4.130 Impact Factor

Functional and genetic deconstruction of the cellular origin in liver cancer.

Nat Rev Cancer 2015 Nov;15(11):653-67

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc4017DOI Listing
November 2015
15 Reads
37 Citations
37.400 Impact Factor

Stimulating translational research: several European life science institutions put their heads together.

Trends Mol Med 2015 Sep 5;21(9):525-7. Epub 2015 Aug 5.

EU-Life Translational Working Group; Centre for Genomic Regulation (CRG), Dr Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2015.07.002DOI Listing
September 2015
52 Reads
1 Citation
9.453 Impact Factor

Fibrolamellar hepatocellular carcinoma: a rare but distinct type of liver cancer.

Gastroenterology 2015 Apr 24;148(4):707-10. Epub 2015 Feb 24.

Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.02.039DOI Listing
April 2015
4 Reads
1 Citation
16.720 Impact Factor

Molecular pathogenesis of intrahepatic cholangiocarcinoma.

J Hepatobiliary Pancreat Sci 2015 Feb 1;22(2):101-13. Epub 2014 Sep 1.

Andersen Group, Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, DK-2200, Copenhagen N, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jhbp.155DOI Listing
February 2015
22 Reads
7 Citations
2.313 Impact Factor

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.

Hepat Oncol 2015;2(1):79-93

Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, 2200 Copenhagen N, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/hep.14.24DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523883PMC
January 2015
9 Reads
2 Citations

Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.

J Hepatol 2015 Jan 16;62(1):198-207. Epub 2014 Sep 16.

Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2014.09.007DOI Listing
January 2015
10 Reads
12 Citations
11.340 Impact Factor

MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

Cancer Res 2014 Oct 4;74(20):5903-13. Epub 2014 Sep 4.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199878PMC
October 2014
21 Reads
20 Citations
9.330 Impact Factor

p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.

Cell 2014 Jul;158(3):579-92

Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA; Howard Hughes Medical Institute, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2014.05.051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221237PMC
July 2014
26 Reads
35 Citations
32.242 Impact Factor

Epigenetic reprogramming modulates malignant properties of human liver cancer.

Hepatology 2014 Jun 1;59(6):2251-62. Epub 2014 May 1.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.27026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043911PMC
June 2014
13 Reads
22 Citations
11.055 Impact Factor

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends.

J Hepatol 2014 Apr 3;60(4):855-65. Epub 2013 Dec 3.

Laboratory of Experimental Carcinogenesis, National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.11.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960348PMC
April 2014
2 Reads
43 Citations
11.340 Impact Factor

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.

J Hepatol 2014 Feb 26;60(2):346-353. Epub 2013 Oct 26.

Laboratory of Experimental Carcinogenesis (LEC), Center for Cancer Research, National Cancer Institute, NIH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.10.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943679PMC
February 2014
17 Reads
19 Citations
11.340 Impact Factor

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Hepat Oncol 2014 Jan;1(1):143-157

National Cancer Institute, Laboratory of Experimental Carcinogenesis, NIH, Building 37, Room 4146A, 37 Convent Drive, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/hep.13.4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997260PMC
January 2014
4 Reads
4 Citations

Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair.

Fibrogenesis Tissue Repair 2013 Dec 20;6(1):21. Epub 2013 Dec 20.

Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1755-1536-6-21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892118PMC
December 2013
48 Reads
3 Citations

Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling.

Genes Dev 2013 Aug;27(15):1706-17

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/gad.214601.113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744728PMC
August 2013
12 Reads
16 Citations
10.800 Impact Factor

Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Gastroenterology 2013 Jul 19;145(1):221-231. Epub 2013 Mar 19.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913051PMC
July 2013
22 Reads
36 Citations
16.720 Impact Factor

Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities.

Gastroenterology 2013 Apr 24;144(4):687-90. Epub 2013 Feb 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.02.018DOI Listing
April 2013
3 Reads
3 Citations
16.720 Impact Factor

Next-generation sequencing: application in liver cancer-past, present and future?

Biology (Basel) 2012 Aug;1(2):383-94

Department of Medicine I, Johannes Gutenberg University, Langenbeckstrasse 1, Mainz 55131, Germany ; Laboratory of Experimental Carcinogenesis, NCI/CCR, NIH, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biology1020383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674503PMC
August 2012
26 Reads
9 Citations

Genetic profiling of intrahepatic cholangiocarcinoma.

Curr Opin Gastroenterol 2012 May;28(3):266-72

Laboratory of Experimental Carcinogenesis, NCI/CCR, NIH, Bethesda, Maryland 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0b013e3283523c7eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017233PMC
May 2012
3 Reads
24 Citations
4.290 Impact Factor

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.

Gastroenterology 2012 Apr 13;142(4):1021-1031.e15. Epub 2011 Dec 13.

Laboratory of Experimental Carcinogenesis, National Institutes of Health, Bethesda, Maryland 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2011.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413201PMC
April 2012
52 Reads
98 Citations
16.720 Impact Factor

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

Hepatology 2011 Sep 27;54(3):1031-42. Epub 2011 Jul 27.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.24454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179780PMC
September 2011
21 Reads
37 Citations
11.055 Impact Factor

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

J Exp Med 2011 Sep 29;208(10):1963-76. Epub 2011 Aug 29.

Department of Genetics, Department of Pediatrics, Stanford University, Stanford, CA, USA; Department of Medical Chemistry, University of Liège, B-4000 Liège, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20110198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182062PMC
September 2011
15 Reads
61 Citations
12.520 Impact Factor

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Cancer Res 2011 Apr 15;71(7):2718-27. Epub 2011 Feb 15.

Cancer and Inflammation Program, NCI-Frederick, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074499PMC
April 2011
50 Reads
23 Citations
9.330 Impact Factor

Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma.

Cancer Res 2010 Nov 19;70(21):8264-9. Epub 2010 Oct 19.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-0749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970744PMC
November 2010
27 Reads
20 Citations
9.330 Impact Factor

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.

Sci Transl Med 2010 Oct;2(54):54ra77

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3001338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077922PMC
October 2010
9 Reads
34 Citations
15.843 Impact Factor

Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice.

PLoS One 2010 Sep 16;5(9). Epub 2010 Sep 16.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012739PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940888PMC
September 2010
36 Reads
28 Citations
3.234 Impact Factor

Progenitor-derived hepatocellular carcinoma model in the rat.

Hepatology 2010 Apr;51(4):1401-9

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.23488DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914300PMC
April 2010
19 Reads
42 Citations
11.055 Impact Factor

Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence.

RNA Biol 2009 Jul-Aug;6(3):305-15. Epub 2009 Jul 23.

Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, School of Medicine, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752476PMC
http://dx.doi.org/10.4161/rna.6.3.8526DOI Listing
November 2009
10 Reads
16 Citations
4.974 Impact Factor

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Mol Cancer Ther 2008 Dec;7(12):3780-8

Department of Pharmacology and Toxicology, Dartmouth Medical School, Remsen 7650, Hanover, NH 03755, USA.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-08
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-08-0753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638083PMC
December 2008
22 Reads
25 Citations
5.683 Impact Factor

Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA.

J Biol Chem 2007 Mar 19;282(11):7950-60. Epub 2007 Jan 19.

University of Maryland, Department of Microbiology and Immunology, Marlene and Stewart Greenebaum Cancer Center, Graduate Program in Molecular Medicine, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M607939200DOI Listing
March 2007
27 Reads
20 Citations
4.573 Impact Factor

Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1.

Eur J Biochem 2004 Feb;271(3):628-36

Department of Molecular Biology (MBI), University of Aarhus, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1432-1033.2003.03966.xDOI Listing
February 2004
5 Reads
6 Citations

Top co-authors

Snorri S Thorgeirsson
Snorri S Thorgeirsson

Laboratory of Experimental Carcinogenesis

27
Jens U Marquardt
Jens U Marquardt

National Cancer Institute

17
Valentina M Factor
Valentina M Factor

Laboratory of Experimental Carcinogenesis

15
Elizabeth A Conner
Elizabeth A Conner

Laboratory of Experimental Carcinogenesis

13
Chiara Raggi
Chiara Raggi

National Cancer Institute

10
Daekwan Seo
Daekwan Seo

Macrogen Corp.

10
Mitsuteru Kitade
Mitsuteru Kitade

Nara Medical University

7
Yun-Han Lee
Yun-Han Lee

National Cancer Institute

6
Marian E Durkin
Marian E Durkin

National Cancer Institute

4